An interventional study of Rehabilitation with VRRS and Conventional cognitive training in Autism Spectrum Disorder and Intellectual Disability, sponsored by IRCCS Centro Neurolesi Bonino Pulejo. Enrolling by invitation at 1 site in Italy. Open to participants aged 6 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-10-08.
Sponsored by IRCCS Centro Neurolesi Bonino Pulejo · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 90 studies in Autism Spectrum Disorder with a site in Italy — 48 open to participants now, 55 under way, 1 of them phase 3. Autism Spectrum Disorder · Italy.
Among the 90 studies in Autism Spectrum Disorder with a site in Italy, this one is the 17th largest by planned enrollment of the 63 interventional ones that give a count, is one of 24 that started in 2023, is one of 51 with no phase, reaches primary completion later than 29 of the 54 other live ones, and was the 46th registered.
1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.
Browse Autism Spectrum Disorder studies →48 of the 90 studies in Autism Spectrum Disorder with a site in Italy are open now. Recruiting first, the newest first:
University of Milan · Sites in Italy
Ages 6–14
IRCCS San Raffaele Roma · Sites in Italy
Ages 2–18 · Healthy volunteers
Istituto per la Ricerca e l'Innovazione Biomedica · Sites in Italy
Ages 6–13
Antonella Costantino · Sites in Italy
Ages 0–11
Istituto per la Ricerca e l'Innovazione Biomedica · Sites in Italy
Ages 4–12 · Healthy volunteers
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.
This study: 6 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 9 · Phase 3 6
First in 2012; this study’s year is marked. 24 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 52 across 1,374 interventional studies indexed under Autism Spectrum Disorder.
Median enrollment 50 across the 63 interventional studies, 100 across the 27 observational. Of the 31 that completed or were terminated, 8 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 90 have an industry lead sponsor. The 10 most frequent:
IRCCS Centro Neurolesi Bonino Pulejo is the lead sponsor of 67 studies on the registry; 30 are open to participants now.
IRCCS Centro Neurolesi Bonino Pulejo has 5 studies filed under Autism Spectrum Disorder — fewer than ten, so there is no comparison to draw.
11 of the studies in Autism Spectrum Disorder with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06514573Istituto Superiore di SanitàButyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders | 2026-11 |
| NCT07519369IRCCS San Raffaele RomaMonitoring Daily Mobility in Children With Autism | 2026-12 |
| NCT07389720IRCCS Eugenio MedeaCharacterization of (A)Typical Sensorimotor Pathways in Individuals With Autism | 2026-12 |
| NCT07470138IRCCS Eugenio MedeaSleep Disturbance in Subjects With Autism Spectrum Disorders (ASD) in Preschool Age (18-60 Months) | 2026-12-15 |
| NCT07643649Istituto per la Ricerca e l'Innovazione BiomedicaCognitive Training in Virtual Reality for Autism | 2026-12-31 |
Add all 11 to your calendar (.ics) → With an account.
Among the 90 studies in Autism Spectrum Disorder with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Intellectual disability (ID) and autism spectrum disorder (ASD) are often co-occurring neurodevelopmental disorders that require composite intervention. However, standardized rehabilitation programs presented several limitations due to behavioral problems and poor engagement in proposed activity. The Virtual Reality Rehabilitation System (VRRS) is a medical device is recognized as one of the most advanced systems to rehabilitate patients with motor, cognitive, linguistic and behavioral disorders. The use of VRRS offers the opportunity to adapting task parameters according to the patient's performance and the virtual system increases engagement and avoids boredom and frustration. the patients underwent a two months experimental intervention integrated into the regular activity of a semi-residential center for autistic adolescents and young adults.
The criteria were revised on the registry on Oct 8, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The group consists of patients diagnosed with autism spectrum disorder and intellectual disability who underwent treatment with VRRS
Device: Rehabilitation with VRRS
Patients diagnosed with autism spectrum disorder and intellectual disability underwent to conventional cognitive training
Behavioral: Conventional cognitive training
The patients underwent an experimental intervention lasting two months (9 sessions lasting about 40 minutes) integrated into the regular activity of a semi-residential center for autistic adolescents and young adults. The proposed exercises were 2D and the patient interacted with the scenarios through the touch screen. For all participants, the tasks were the same, but difficulty and duration varied according to the needs and goals to be achieved.
Conventional cognitive training consisted of structured paper-and-pencil tasks and therapist-guided activities targeting multiple cognitive domains, including attention, visual-spatial processing, sustained attention, working memory, and problem-solving. These exercises were administered individually by a trained therapist and tailored to each participant's functional level. The intervention lasting two months (9 sessions, lasting about 40 minutes) integrated into regular activity of semi-residential center for autistic adolescents and young adults.
Usability questionnaire
The questionnaire used a 5-point ordinal scale, where 5 is the most favorable score and 1 is the least favorable score; the score 3 corresponds to "no opinion". The questionnaire will be completed by all therapists at the end of the treatment.
Time frame: T0 (BASELINE) - T1 (SIX MONTHS)
Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: screen attention time
During the execution of the exercise, the attention time maintained on the screen was recorded.
Time frame: T0 (BASELINE) -T1 (SIX MONTHS)
Virtual Reality Rehabilitation System (VRRS) electromedical device parameters: the number of repetitions of the exercises.
During the execution of the exercise, the number of repetitions of the exercises was recorded
Time frame: T0 (BASELINE) -T1 (SIX MONTHS)
Virtual Reality Rehabilitation System (VRRS) electromedical device parameters:global scores for exercise.
The total scores obtained were recorded during the execution of the exercise.
Time frame: T0 (BASELINE) -T1 (SIX MONTHS)
Ran from Apr 2023 to primary completion in Sep 2025, 29 months.
Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's 29 months is above that.
Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.
Completion moved once since we started tracking on Sep 25, 2026: Sep 2025 → Sep 2026, on Oct 8, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Centro Neurolesi Bonino Pulejo